Modest correlation between IVUS and FFR in intermediate lesions assessment

Original title: FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study Reference: Ron Waksman et al. J Am Coll Cardiol 2013. Article in Press

For patients with angiographically assessed intermediate lesions such as stenosis between 40% and 80%, criteria that favor revascularization remains under debate. 

Fractional Flow Reserve (FFR) is considered the gold standard to assess intermediate lesions, and ≤ 0.8 is considered a significative value. Intravascular ultrasound has traditionally used a 4 mm2 cut-off minimum lumen area (MLA) to classify a lesion as severe; however, this cut-off IVUS value has not been proved equivalent to the functional parameter of FFR.

This prospective, multicenter registry designed to determine the correlation between FFR, IVUS and virtual histology (VH) in intermediate lesions included 350 patients (367 intermediate lesions). Whether to perform an angioplasty procedure or not was the operator’s decision.

ROC analysis identified the 3.07 mm2 global MLA cut-off by IVUS as the best threshold to indentify <0.8 FFR lesions (64% sensitivity, 64% specificity). This global MLA cut-off changes according to the vessel’s reference diameter. For vessels < 3.0 mm in diameter, MLA is <2.4 mm2, vessels between 3.0 and 3.5 mm, MLA = <2.7 mm2 and vessels >3.5 mm, MLA = <3.6 mm2. With these optimal MLA cut-offs by IVUS, taking FFR as gold standard, false positives reached 25.7%. A plaque burden of 68.7 ± 11.2% was the only HV variable which correlated with a <0.8 FFR.

Conclusion 

Anatomical measurement by intravascular ultrasound has a moderate correlation with FFR and depends on the reference diameter.

Comment 

The therapeutic decision for an intermediate lesion should be taken, firstly, following clinical criteria, since both techniques present limitations. IVUS may be a better tool to guide the strategy and monitor the final outcome of an angioplasty procedure, rather than to decide whether to perform it or not.

SOLACI.ORG

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...